Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 2Leukemia 2Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Hematologic Neoplasms 1Desmoplastic Small Round Cell Tumor 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 2Methods 2Educational Status 2Early Intervention, Educational 2trihexyltetradecylphosphonium chloride 1letermovir 1gamma-Globulins 1Voriconazole 1Vincristine 1Vaccination 1Sirolimus 1Prednisone 1Pharmacogenomic Testing 1Patient Navigation 1Organizational Objectives 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Lenalidomide 1Interviews as Topic 1Infliximab 1Immunoglobulins, Intravenous 1Immunoglobulins 1Health Promotion 1Fluconazole 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Caspofungin 1Carvedilol 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hematologic Neoplasms × Pharmacogenomic Testing × Clear all
NCT02717507 2025-04-23

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

Children's Oncology Group

Phase 2 Completed
196 enrolled 26 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡